102
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study

, , , & , PhD DDS
Pages S109-S115 | Published online: 07 Apr 2010

Bibliography

  • Report of a World Health Organization Scientific Group. Prevention and management of osteoporosis. Geneva: World Health Organization technical report series 2003; No 921
  • Morgan HM, Shakeshaft JT, Lillicrap SC. Gamma-ray scattering for mandibular bone density measurement. Br J Radiol 1999;72:1069-72
  • Yamada K, Kohno N. Cancer treatment-induced bone loss. Treatment for breast cancer. Clin Calcium 2008;18:507-17
  • Doridot V, Nos C, Aucouturier JS, Breast-conserving therapy of breast cancer. Cancer Radiother 2004;8:21-8
  • Waltman NL, Ott CD, Twiss JJ, Bone mineral density and bone turnover in postmenopausal women treated for breast cancer. Cancer Nurs 2008;31:182-90
  • Saarto R, Blomqvist C, Valimake M, Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 1997;15:1341-7
  • Casciato D. Manual of clinical oncology. 5th edition. Lippincott Williams & Wilkins, Philadelphia, PA; 2004
  • Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P. Adverse bone effects during pharmacological breast cancer therapy. Acta Oncol 2008;47:747-54
  • Davies JH, Evans BA, Jenney ME, Gregory JW. In vitro effects of chemotherapeutic agents on human osteoblast-like cells. Calcif Tissue Int 2002;70:408-15
  • Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 2000;18:1570-93
  • Fogelman I, Blake GM, Blamey R, Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Osteoporos Int 2003;14:1001-6
  • Powles TJ, McCloskey E, Paterson AG, Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer. J Natl Cancer Inst 1998;90:704-8
  • Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001;19:3306-11
  • Vehmanen L, Elomaa I, Blomqvist C, Saarto T. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 2006;24:675-80
  • Hadji P, Ziller M, Maskow C, The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur J Cancer 2009;45:3205-12
  • Horner K, Devlin H, Alsop CW, Mandibular bone mineral density as a predictor of skeletal osteoporosis. Br J Radiol 1996;69:1019-25
  • Pluskiewicz W, Tarnawska B, Drozdzowska B. Mandibular bone mineral density measured using dual-energy X-ray absorptiometry: relationship to hip bone mineral density and quantitative ultrasound at calcaneus and hand phalanges. Br J Radiol 2000;73:288-92
  • Drage NA, Palmer RM, Blake G, A comparison of bone mineral density in the spine, hip and jaws of edentulous subjects. Clin Oral Implants Res 2007;18:496-500
  • Zhou Y, Zhou S, Xue Y. The comparison of bone densities of mandible and coxofemoral region between senile people with edentulous jaws and those with dentate jaws. Chin J Stomatol 1999;34:361-3
  • Choel L, Duboeuf F, Bourgeois D, Trabecular alveolar bone in the human mandible: a dual-energy X-ray absorptiometry study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:364-70
  • Bassi F, Procchio M, Fava C, Bone density in human dentate and edentulous mandibles using computed tomography. Clin Oral Implants Res 1999;10:356-61
  • Vehmanen L, Saarto T, Elomaa O, Long-term impact of chemotherapy-induced ovarian failure on bone material density (BMD) in premenopausal breast cancer patients: the effect of adjuvant clodronate treatment. Eur J Cancer 2001;37:2373-8
  • National Institutes of Health. Osteoporosis and related bone disease. National Resource Center, National Institutes of Health, Bethesda, MD; 2003
  • Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol 2003;6:763-75
  • Hajjar RR, Kamel HK. Osteoporosis for the home care physician, part 1: etiology and current diagnostic strategies. J Am Med Dir Assoc 2004;5:192-6
  • Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-29
  • Delmas PD, Fontana A. Bone loss induced by cancer treatment and its management. Eur J Cancer 1998;34:260-2
  • Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 2000;18:1570-93
  • Fitzpatrick LA. Oestrogen therapy for postmenopausal osteoporosis. Arq Bras Endocrinol Metabol 2006;50:705-19
  • Knezović Zlatarić D, Pandurić J, Korsić M, Dodig D. Assessment tools in early detection of osteoporosis in dentistry. Arh Hig Rada Toksikol 2007;58:33-9
  • U.S Pharmacist. Counseling Patients with Dentures Jobson Publishing; 1999. p. 24
  • Carlsson GE. Clinical morbidity and sequelae of treatment with complete dentures. J Prosthet Dent 1998;79:17-23
  • Shibli JA, Aguiar KC, Melo L, Histologic analysis of human peri-implant bone in Type 1 osteoporosis. J Oral Implantol 2008;34:12-6
  • Balshi TJ, Wolfinger GJ. Dental implants in the diabetic patient: a retrospective study. Implant Dent 1999;8:355-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.